Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer Meeting Abstract
| Authors: | Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; Regazzi, A. M.; Jihad, M.; Bajorin, D. F.; Balar, A. V.; Mortazavi, A.; Merghoub, T.; Iyer, G.; Rosenberg, J. E.; Greenbaum, B.; Funt, S. A. |
| Abstract Title: | Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301404 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4584 |
| Notes: | Meeting Abstract: 4584 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
